ALXO
ALX OncologyยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
ALXO Profile
Alx Oncology Holdings Inc.
A clinical-stage immuno-oncology company that develops immuno-oncology therapies for the treatment of cancer
Biological Technology
04/01/2020
07/17/2020
NASDAQ Stock Exchange
80
12-31
Common stock
323 Allerton Avenue, South San Francisco, California 94080
--
ALX Oncology Holdings Inc. Incorporated on April 1, 2020. The company is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing therapies that block CD47 immune checkpoints and connect the innate and adaptive immune systems.
